Trial intelligence / Profile preview

Lactitol and Probiotics for OXA-48 Klebsiella pneumoniae Decolonization

NCT02307383Phase 2Unknown

Sponsor
Hospital La Paz Institute for Health Research
Start
Oct 2014
Primary completion
Oct 2015
Modality
Small Molecules, Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 2 trial of lactitol, lactobacillus acidophilus, bifidobacterium bifidum in Klebsiella pneumoniae colonization, sponsored by Hospital La Paz Institute for Health Research. Status: unknown.

02

Drugs

lactitollactobacillus acidophilusbifidobacterium bifidum
03

Conditions

Klebsiella pneumoniae colonization

Beyond the preview

Go deeper on NCT02307383.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02307383.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call